Sign In

James McCullough

Chief Executive Officer

James McCullough is the co-founder and Chief Executive Officer of Renalytix, a position he has held since the company's inception in 2018.12 He has extensive leadership experience in building emerging technology companies, particularly in the life sciences industry.2

Prior to Renalytix, McCullough served as the CEO of Exosome Diagnostics Inc. from 2008 to 2014, a venture-backed personalized medicine company developing non-invasive liquid biopsy diagnostics in cancer.12 Since 2014, he has also been a managing partner at Renwick Capital, LLC, a management consulting firm specializing in assisting emerging healthcare technology companies.13

McCullough's current roles include:

  • CEO of Renalytix (since 2018)3
  • Managing Partner at Renwick Capital, LLC (since 2014)3
  • Director at The Bonnie J. Addario Lung Cancer Foundation13
  • Director at Kantaro Biosciences LLC1
  • Non-Executive Director at Verici Dx Plc (since 2020)1

He has also held positions as Chairman at BalletNext, Inc. and Director at Go2 Foundation For Lung Cancer.1

McCullough received his B.A. from Boston University and an MBA from Columbia Business School.12 He is based in Park City, Utah.3

Highlights

Oct 27 · GlobeNewswire
Renalytix AI plc (“RenalytixAI” or the “Company”) Full Year Report - GlobeNewswire
Oct 27 · GlobeNewswire
Renalytix AI plc (“RenalytixAI” or the “Company”) Full Year Report - GlobeNewswire

Related Questions

What are James McCullough's key achievements at Renalytix?
How did James McCullough transition from Exosome Diagnostics to Renalytix?
What is the mission of Paige AI, Inc. founded by James McCullough?
What are James McCullough's roles at The Bonnie J. Addario Lung Cancer Foundation and Go2 Foundation For Lung Cancer?
How has James McCullough's leadership style influenced Renalytix's growth?
J
Add to my network

Location

Park City, Utah, United States